×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 8: Quality Assurance in Drug Development (GxPs)
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- Good Clinical Practices
- Institutional Review Boards
- Informed Consent
- Good Laboratory Practices
- Good Manufacturing Practices
Have an account?